Pasithea Therapeutics Announces Intention To Commence A $4M Tender Offer For 5.7M Shares Of Its Common Stock At Price Of $0.70/Share
Portfolio Pulse from Benzinga Newsdesk
Pasithea Therapeutics has announced its intention to commence a $4M tender offer for 5.7M shares of its common stock at a price of $0.70 per share.
July 20, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pasithea Therapeutics' announcement of a $4M tender offer for 5.7M shares at $0.70/share could impact its stock price.
The announcement of a tender offer usually leads to increased trading activity and can cause fluctuations in the stock price. However, the direction of the price movement can be uncertain and depends on various factors, including investor sentiment and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100